Roles of connexins in atherosclerosis and ischemia-reperfusion injury

Current Pharmaceutical Biotechnology

Volumn 13, Issue 1, 2012, Pages 17-26

  Morel, Sandrine ^a   Kwak, Brenda R ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Atherosclerosis; Connexin; Gap junction; Hemichannels; Ischemia reperfusion; Preconditioning

Indexed keywords

AAP10 PEPTIDE; CONNEXIN 37; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; CONNEXON; GAP JUNCTION CHANNEL; GAP JUNCTION PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE; PROTEIN; ROTIGAPTIDE; RXP PEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CAROTID ARTERY OBSTRUCTION; CELL SURVIVAL; CORONARY ARTERY OBSTRUCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GAP JUNCTION; GENE DELETION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; ISCHEMIC PRECONDITIONING; MACROPHAGE; MOLECULAR DOCKING; MONOCYTE; NONHUMAN; PROTEIN DOMAIN; REPERFUSION INJURY; REVIEW; SMOOTH MUSCLE FIBER;

ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; CONNEXINS; GAP JUNCTIONS; HUMANS; MYOCARDIUM; REPERFUSION INJURY;

RUMEX;

EID: 84855827472     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112798868638     Document Type: Review

References (145)

1. Balakumar, P.; Rohilla, A.; Singh, M. Pre-conditioning and post conditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep? Pharmacol. Res., 2008, 57, 403-412.
2. Virmani, R.; Burke, A. P.; Farb, A.; Kolodgie, F.D. Pathology of the vulnerable plaque. J. Am. Coll. Cardiol., 2006, 47, C13-18.
3. Libby, P. Inflammation in atherosclerosis. Nature, 2002, 420, 868-874.
4. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 2005, 352, 1685-1695.
5. Thomas, M. A.; Huang, S.; Cokoja, A.; Riccio, O.; Staub, O.; Suter, S.; Chanson, M. Interaction of connexins with protein partners in the control of channel turnover and gating. Biol. Cell, 2002, 94, 445-456.
6. Duffy, H. S.; Delmar, M.; Spray, D. C. Formation of the gap junction nexus: binding partners for connexins. J. Physiol. Paris, 2002, 96, 243-249.
7. Giepmans, B. N. Gap junctions and connexin-interacting proteins. Cardiovasc. Res., 2004, 62, 233-245.
8. Chanson, M.; Kwak, B. R. Connexin37: a potential modifier gene of inflammatory disease. J. Mol. Med., 2007, 85, 787-795.
9. Martin, P. E.; Evans, W. H. Incorporation of connexins into plasma membranes and gap junctions. Cardiovasc. Res., 2004, 62, 378-387.
10. Plum, A.; Hallas, G.; Magin, T.; Dombrowski, F.; Hagendorff, A.; Schumacher, B.; Wolpert, C.; Kim, J.; Lamers, W. H.; Evert, M.; Meda, P.; Traub, O.; Willecke, K. Unique and shared functions of different connexins in mice. Curr. Biol., 2000, 10, 1083-1091.
11. White, T. W. Nonredundant gap junction functions, News Physiol. Sci., 2003, 18, 95-99.
12. Wolfle, S. E.; Schmidt, V. J.; Hoepfl, B.; Gebert, A.; Alcolea, S.; Gros, D.; de Wit, C. Connexin45 cannot replace the function of connexin40 in conducting endothelium-dependent dilations along arterioles. Circ. Res., 2007, 101, 1292-1299.
13. Johnstone, S.; Isakson, B.; Locke, D. Biological and biophysical properties of vascular connexin channels. Int. Rev. Cell Mol. Biol., 2009, 278, 69-118.
14. Kumar, N. M.; Gilula, N.B. The gap junction communication channel. Cell, 1996, 84, 381-388.
15. Sohl, G.; Willecke, K. An update on connexin genes and their nomenclature in mouse and man. Cell Commun. Adhes, 2003, 10, 173-180.
16. Saez, J. C.; Berthoud, V. M.; Branes, M. C.; Martinez, A.D.; Beyer, E. C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol. Rev., 2003, 83, 1359-1400.
17. Thomas, T.; Jordan, K.; Laird, D.W. Role of cytoskeletal elements in the recruitment of Cx43-GFP and Cx26-YFP into gap junctions. Cell Commun. Adhes., 2001, 8, 231-236.
18. Johnson, R.G.; Meyer, R.A.; Li, X.R.; Preus, D.M.; Tan, L.; Grunenwald, H.; Paulson, A.F.; Laird, D. W.; Sheridan, J.D. Gap junctions assemble in the presence of cytoskeletal inhibitors, but enhanced assembly requires microtubules. Exp. Cell Res., 2002, 275, 67-80.
19. Laird, D.W. Life cycle of connexins in health and disease. Biochem J., 2006, 394, 527-543.
20. John, S.; Cesario, D.; Weiss, J.N. Gap junctional hemichannels in the heart. Acta Physiol Scand., 2003, 179, 23-31.
21. Derouette, J.P.; Desplantez, T.; Wong, C.W.; Roth, I.; Kwak, B.R.; Weingart, R. Functional differences between human Cx37 polymorphic hemichannels. J. Mol. Cell Cardiol., 2008.
22. Goodenough, D.A.; Paul, D.L. Beyond the gap: functions of unpaired connexon channels. Nat Rev. Mol. Cell Biol., 2003, 4, 285-294.
23. Evans, W.H.; Martin, P.E. Gap junctions: structure and function (Review). Mol. Member Biol., 2002, 19, 121-136.
24. Little, T.L.; Beyer, E.C.; Duling, B.R. Connexin 43 and connexin 40 gap junctional proteins are present in arteriolar smooth muscle and endothelium in vivo. Am. J. Physiol., 1995, 268, H729-739.
25. Haefliger, J.A.; Polikar, R.; Schnyder, G.; Burdet, M.; Sutter, E.; Pexieder, T.; Nicod, P.; Meda, P. Connexin37 in normal and pathological development of mouse heart and great arteries. Dev Dyn, 2000, 218, 331-344.
26. Gabriels, J.E.; Paul, D.L. Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ. Res., 1998, 83, 636-643.
27. Haefliger, J.A.; Nicod, P.; Meda, P. Contribution of connexins to the function of the vascular wall. Cardiovasc. Res., 2004, 62, 345-356.
28. de Wit, C.; Hoepfl, B.; Wolfle, S.E. Endothelial mediators and communication through vascular gap junctions. Biol. Chem., 2006, 387, 3-9.
29. Brisset, A.C.; Isakson, B.E.; Kwak, B.R. Connexins in vascular physiology and pathology. Antioxid Redox Signal., 2009, 11, 267-282.
30. Straub, A.C.; Johnstone, S.R.; Heberlein, K.R.; Rizzo, M.J.; Best, A.K.; Boitano, S.; Isakson, B. E. Site-Specific Connexin Phosphorylation Is Associated with Reduced Heterocellular Communication between Smooth Muscle and Endothelium. J. Vasc. Res., 2009, 47, 277-286.
31. Severs, N.J.; Rothery, S.; Dupont, E.; Coppen, S.R.; Yeh, H.I.; Ko, Y.S.; Matsushita, T.; Kaba, R.; Halliday, D. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc. Res. Tech., 2001, 52, 301-322.
32. Villar, I.C.; Francis, S.; Webb, A.; Hobbs, A.J.; Ahluwalia, A. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int., 2006, 70, 840-853.
33. Bellien, J.; Thuillez, C.; Joannides, R. Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans. Fundam Clin. Pharmacol., 2008, 22, 363-377.
34. de Wit, C.; Boettcher, M.; Schmidt, V.J. Signaling across myoendothelial gap junctions--fact or fiction?, Cell Commun. Adhes., 2008, 15, 231-245.
35. Sandow, S.L.; Haddock, R.E.; Hill, C.E.; Chadha, P.S.; Kerr, P.M.; Welsh, D.G.; Plane, F. What's where and why at a vascular myoendothelial microdomain signalling complex. Clin Exp. Pharmacol Physiol., 2009, 36, 67-76.
36. De Wit, C. Connexins pave the way for vascular communication. News Physiol Sci., 2004, 19, 148-153.
37. Segal, S.S. Regulation of blood flow in the microcirculation. Microcirculation, 2005, 12, 33-45.
38. Kruger, O.; Plum, A.; Kim, J.S.; Winterhager, E.; Maxeiner, S.; Hallas, G.; Kirchhoff, S.; Traub, O.; Lamers, W.H.; Willecke, K. Defective vascular development in connexin 45-deficient mice. Development, 2000, 127, 4179-4193.
39. Reaume, A.G.; de Sousa, P.A.; Kulkarni, S.; Langille, B.L.; Zhu, D.; Davies, T.C.; Juneja, S.C.; Kidder, G.M.; Rossant, J. Cardiac malformation in neonatal mice lacking connexin43. Science, 1995, 267, 1831-1834.
40. de Wit, C.; Roos, F.; Bolz, S.S.; Pohl, U. Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol. Genomics, 2003, 13, 169-177.
41. Simon, A.M.; Goodenough, D.A.; Paul, D.L. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol., 1998, 8, 295-298.
42. Kirchhoff, S.; Nelles, E.; Hagendorff, A.; Kruger, O.; Traub, O.; Willecke, K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr. Biol., 1998, 8, 299-302.
43. Simon, A.M.; McWhorter, A.R. Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol., 2002, 251, 206-220.
44. Simon, A.M.; McWhorter, A.R. Decreased intercellular dyetransfer and downregulation of non-ablated connexins in aortic endothelium deficient in connexin37 or connexin40. J. Cell Sci., 2003, 116, 2223-2236.
45. Kruger, O.; Beny, J.L.; Chabaud, F.; Traub, O.; Theis, M.; Brix, K.; Kirchhoff, S.; Willecke, K. Altered dye diffusion and upregulation of connexin37 in mouse aortic endothelium deficient in connexin40, J. Vasc. Res., 2002, 39, 160-172.
46. Wong, C.W.; Christen, T.; Roth, I.; Chadjichristos, C.E.; Derouette, J.P.; Foglia, B.F.; Chanson, M.; Goodenough, D.A.; Kwak, B.R. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat. Med., 2006, 12, 950-954.
47. Pfenniger, A.; Derouette, J.P.; Verma, V.; Lin, X.; Foglia, B.; Coombs, W.; Roth, I.; Satta, N.; Dunoyer-Geindre, S.; Sorgen, P.; Taffet, S.; Kwak, B. R.; Delmar, M. Gap junction protein Cx37 interacts with endothelial nitric oxide synthase in endothelial cells. Arterioscler Thromb. Vasc. Biol., 2010, 30, 827-834.
48. Feron, O.; Belhassen, L.; Kobzik, L.; Smith, T.W.; Kelly, R.A.; Michel, T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem., 1996, 271, 22810-22814.
49. Rath, G.; Dessy, C.; Feron, O. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation. J. Physiol. Pharmacol., 2009, 60 Suppl 4, 105-109.
50. Zhang, S.H.; Reddick, R.L.; Piedrahita, J.A.; Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science, 1992, 258, 468-471.
51. Ishibashi, S.; Brown, M.S.; Goldstein, J.L.; Gerard, R.D.; Hammer, R.E.; Herz, J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest., 1993, 92, 883-893.
52. Guerrero, P.A.; Schuessler, R.B.; Davis, L.M.; Beyer, E.C.; Johnson, C.M.; Yamada, K.A.; Saffitz, J. E. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J. Clin. Invest., 1997, 99, 1991-1998.
53. de Wit, C.; Roos, F.; Bolz, S.S.; Kirchhoff, S.; Kruger, O.; Willecke, K.; Pohl, U. Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ. Res., 2000, 86, 649-655.
54. Theis, M.; de Wit, C.; Schlaeger, T.M.; Eckardt, D.; Kruger, O.; Doring, B.; Risau, W.; Deutsch, U.; Pohl, U.; Willecke, K. Endothelium-specific replacement of the connexin43 coding region by a lacZ reporter gene. Genesis., 2001, 29, 1-13.
55. Chadjichristos, C.E.; Scheckenbach, K.E.; van Veen, T.A.; Richani Sarieddine, M.Z.; de Wit, C.; Yang, Z.; Roth, I.; Bacchetta, M.; Viswambharan, H.; Foglia, B.; Dudez, T.; van Kempen, M.J.; Coenjaerts, F. E.; Miquerol, L.; Deutsch, U.; Jongsma, H.J.; Chanson, M.; Kwak, B.R. Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion. Circulation, 2010, 121, 123-131.
56. Morel, S.; Sutter, E.; Roth, I.; Foglia, B.; Deutsch, U.; Theis, M.; Kwak, B.R. In. Circulation, 2008; Vol. 118, pp. S473.
57. Simon, A.M.; Goodenough, D.A.; Li, E.; Paul, D.L. Female infertility in mice lacking connexin 37. Nature, 1997, 385, 525-529.
58. Figueroa, X.F.; Duling, B.R. Dissection of two Cx37-independent conducted vasodilator mechanisms by deletion of Cx40: electrotonic versus regenerative conduction. Am. J. Physiol. Heart Circ. Physiol., 2008, 295, H2001-2007.
59. Blackburn, J.P.; Peters, N.S.; Yeh, H.I.; Rothery, S.; Green, C.R.; Severs, N.J. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler Thromb. Vasc. Biol., 1995, 15, 1219-1228.
60. Kwak, B.R.; Mulhaupt, F.; Veillard, N.; Gros, D.B.; Mach, F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb. Vasc. Biol., 2002, 22, 225-230.
61. Polacek, D.; Lal, R.; Volin, M.V.; Davies, P.F. Gap junctional communication between vascular cells. Induction of connexin43 messenger RNA in macrophage foam cells of atherosclerotic lesions, Am. J. Pathol., 1993, 142, 593-606.
62. Kwak, B.R.; Silacci, P.; Stergiopulos, N.; Hayoz, D.; Meda, P. Shear stress and cyclic circumferential stretch, but not pressure, alter connexin43 expression in endothelial cells. Cell Commun. Adhes., 2005, 12, 261-270.
63. Cowan, D.B.; Lye, S.J.; Langille, B.L. Regulation of vascular connexin43 gene expression by mechanical loads. Circ. Res., 1998, 82, 786-793.
64. Kwak, B.R.; Veillard, N.; Pelli, G.; Mulhaupt, F.; James, R.W.; Chanson, M.; Mach, F. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation, 2003, 107, 1033-1039.
65. Rennick, R.E.; Connat, J.L.; Burnstock, G.; Rothery, S.; Severs, N.J.; Green, C.R. Expression of connexin43 gap junctions between cultured vascular smooth muscle cells is dependent upon phenotype, Cell Tissue Res., 1993, 271, 323-332.
66. Chadjichristos, C.E.; Morel, S.; Derouette, J.P.; Sutter, E.; Roth, I.; Brisset, A.C.; Bochaton-Piallat, M. L.; Kwak, B.R. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ. Res., 2008, 102, 653-660.
67. Yeh, H.I.; Lu, C.S.; Wu, Y.J.; Chen, C.C.; Hong, R.C.; Ko, Y.S.; Shiao, M.S.; Severs, N.J.; Tsai, C.H. Reduced expression of endothelial connexin37 and connexin40 in hyperlipidemic mice: recovery of connexin37 after 7-day simvastatin treatment. Arterioscler Thromb. Vasc. Biol., 2003, 23, 1391-1397.
68. Wong, C.W.; Christen, T.; Kwak, B.R. Connexins in leukocytes: shuttling messages? Cardiovasc. Res., 2004, 62, 357-367.
69. Weber, C.; Zernecke, A.; Libby, P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol., 2008, 8, 802-815.
70. Johnson, J.L.; Newby, A.C. Macrophage heterogeneity in atherosclerotic plaques. Curr. Opin. Lipidol., 2009, 20, 370-378.
71. Zahler, S.; Hoffmann, A.; Gloe, T.; Pohl, U. Gap-junctional coupling between neutrophils and endothelial cells: a novel modulator of transendothelial migration. J. Leukoc Biol., 2003, 73, 118-126.
72. Jara, P.I.; Boric, M.P.; Saez, J.C. Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischemia-reperfusion, Proc. Natl. Acad Sci. U S A., 1995, 92, 7011-7015.
73. Leybaert, L.; Braet, K.; Vandamme, W.; Cabooter, L.; Martin, P.E.; Evans, W.H. Connexin channels, connexin mimetic peptides and ATP release. Cell Commun. Adhes, 2003, 10, 251-257.
74. Derouette, J.P.; Wong, C.; Burnier, L.; Morel, S.; Sutter, E.; Galan, K.; Brisset, A.C.; Roth, I.; Chadjichristos, C.E.; Kwak, B.R. Molecular role of Cx37 in advanced atherosclerosis: a micro-array study. Atherosclerosis, 2009, 206, 69-76.
75. Hou, C.J.; Tsai, C.H.; Yeh, H.I. Endothelial connexins are downregulated by atherogenic factors. Front Biosci., 2008, 13, 3549-3557.
76. Heil, S.G.; De Vriese, A.S.; Kluijtmans, L.A.; Mortier, S.; Den Heijer, M.; Blom, H.J. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation. Cell Mol. Biol. (Noisy-le-grand). 2004, 50, 911-916.
77. van Rijen, H.V.; van Kempen, M.J.; Postma, S.; Jongsma, H.J. Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine, 1998, 10, 258-264.
78. Zernecke, A.; Bidzhekov, K.; Ozuyaman, B.; Fraemohs, L.; Liehn, E.A.; Luscher-Firzlaff, J.M.; Luscher, B.; Schrader, J.; Weber, C. CD73/ecto-5'-nucleotidase protects against vascular inflammation and neointima formation. Circulation, 2006, 113, 2120-2127.
79. Gros, D.; Dupays, L.; Alcolea, S.; Meysen, S.; Miquerol, L.; Theveniau-Ruissy, M. Genetically modified mice: tools to decode the functions of connexins in the heart-new models for cardiovascular research. Cardiovasc. Res., 2004, 62, 299-308.
80. Severs, N. J. Connexins A guide-Connexins in the Heart. Humana Press. 2009.
81. Coppen, S.R.; Gourdie, R.G.; Severs, N.J. Connexin45 is the first connexin to be expressed in the central conduction system of the mouse heart. Exp. Clin. Cardiol., 2001, 6, 17-23.
82. Kumai, M.; Nishii, K.; Nakamura, K.; Takeda, N.; Suzuki, M.; Shibata, Y. Loss of connexin45 causes a cushion defect in early cardiogenesis. Development, 2000, 127, 3501-3512.
83. Gu, H.; Smith, F.C.; Taffet, S.M.; Delmar, M. High incidence of cardiac malformations in connexin40-deficient mice. Circ. Res., 2003, 93, 201-206.
84. Huang, G.Y.; Cooper, E.S.; Waldo, K.; Kirby, M.L.; Gilula, N.B.; Lo, C.W. Gap junction-mediated cell-cell communication modulates mouse neural crest migration. J. Cell Biol., 1998, 143, 1725-1734.
85. Sullivan, R.; Huang, G.Y.; Meyer, R.A.; Wessels, A.; Linask, K.K.; Lo, C.W. Heart malformations in transgenic mice exhibiting dominant negative inhibition of gap junctional communication in neural crest cells. Dev. Biol., 1998, 204, 224-234.
86. Kretz, M.; Eckardt, D.; Kruger, O.; Kim, J.S.; Maurer, J.; Theis, M.; van Rijen, H.V.; Schorle, H.; Willecke, K. Normal embryonic development and cardiac morphogenesis in mice with Wnt1-Cremediated deletion of connexin43. Genesis, 2006, 44, 269-276.
87. Liu, S.; Liu, F.; Schneider, A.E.; St. Amand, T.; Epstein, J.A.; Gutstein, D.E. Distinct cardiac malformations caused by absence of connexin 43 in the neural crest and in the non-crest neural tube, Development, 2006, 133, 2063-2073.
88. Angst, B.D.; Khan, L.U.; Severs, N.J.; Whitely, K.; Rothery, S.; Thompson, R.P.; Magee, A.I.; Gourdie, R.G. Dissociated spatial patterning of gap junctions and cell adhesion junctions during postnatal differentiation of ventricular myocardium. Circ. Res., 1997, 80, 88-94.
89. Vozzi, C.; Dupont, E.; Coppen, S.R.; Yeh, H.I.; Severs, N.J. Chamber-related differences in connexin expression in the human heart. J. Mol. Cell Cardiol., 1999, 31, 991-1003.
90. Severs, N. J.; Bruce, A.F.; Dupont, E.; Rothery, S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc. Res., 2008, 80, 9-19.
91. Danik, S.B.; Liu, F.; Zhang, J.; Suk, H.J.; Morley, G.E.; Fishman, G.I.; Gutstein, D.E. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ. Res., 2004, 95, 1035-1041.
92. Kreuzberg, M.M.; Schrickel, J.W.; Ghanem, A.; Kim, J.S.; Degen, J.; Janssen-Bienhold, U.; Lewalter, T.; Tiemann, K.; Willecke, K. Connexin30.2 containing gap junction channels decelerate impulse propagation through the atrioventricular node. Proc. Natl. Acad Sci.(U S A), 2006, 103, 5959-5964.
93. Lampe, P.D.; TenBroek, E.M.; Burt, J.M.; Kurata, W.E.; Johnson, R.G.; Lau, A.F. Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J. Cell Biol., 2000, 149, 1503-1512.
94. TenBroek, E.M.; Lampe, P.D.; Solan, J.L.; Reynhout, J.K.; Johnson, R.G. Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP. J. Cell Biol., 2001, 155, 1307-1318.
95. Takens-Kwak, B.R.; Jongsma, H.J. Cardiac gap junctions: three distinct single channel conductances and their modulation by phosphorylating treatments. Pflugers Arch., 1992, 422, 198-200.
96. Beardslee, M.A.; Lerner, D.L.; Tadros, P.N.; Laing, J.G.; Beyer, E.C.; Yamada, K.A.; Kleber, A.G.; Schuessler, R.B.; Saffitz, J.E. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ. Res., 2000, 87, 656-662.
97. Lampe, P.D.; Cooper, C.D.; King, T.J.; Burt, J.M. Analysis of Connexin43 phosphorylated at S325, S328 and S330 in normoxic and ischemic heart. J. Cell Sci., 2006, 119, 3435-3442.
98. Hatanaka, K.; Kawata, H.; Toyofuku, T.; Yoshida, K. Downregulation of connexin43 in early myocardial ischemia and protective effect by ischemic preconditioning in rat hearts in vivo. Jpn. Heart J., 2004, 45, 1007-1019.
99. Ek-Vitorin, J.F.; King, T.J.; Heyman, N.S.; Lampe, P.D.; Burt, J.M. Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation. Circ. Res., 2006, 98, 1498-1505.
100. Lerner, D.L.; Yamada, K.A.; Schuessler, R.B.; Saffitz, J.E. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation, 2000, 101, 547-552.
101. Maass, K.; Chase, S.E.; Lin, X.; Delmar, M. Cx43 CT Domain Influences Infarct Size and Susceptibility to Ventricular Tachyarrhythmias in Acute Myocardial Infarction. Cardiovasc. Res., 2009.
102. Garcia-Dorado, D.; Rodriguez-Sinovas, A.; Ruiz-Meana, M. Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion, Cardiovasc. Res., 2004, 61, 386-401.
103. Decrock, E.; Vinken, M.; De Vuyst, E.; Krysko, D.V.; D'Herde, K.; Vanhaecke, T.; Vandenabeele, P.; Rogiers, V.; Leybaert, L. Connexin-related signaling in cell death: to live or let die? Cell Death Differ., 2009, 16, 524-536.
104. Kanno, S.; Kovacs, A.; Yamada, K.A.; Saffitz, J.E. Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J. Am. Coll Cardiol., 2003, 41, 681-686.
105. Ruiz-Meana, M.; Garcia-Dorado, D.; Hofstaetter, B.; Piper, H.M.; Soler-Soler, J. Propagation of cardiomyocyte hypercontracture by passage of Na(+) through gap junctions. Circ. Res., 1999, 85, 280-287.
106. Garcia-Dorado, D.; Inserte, J.; Ruiz-Meana, M.; Gonzalez, M.A.; Solares, J.; Julia, M.; Barrabes, J.A.; Soler-Soler, J. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation, 1997, 96, 3579-3586.
107. Schlack, W.; Preckel, B.; Barthel, H.; Obal, D.; Thamer, V. Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart in vivo. Br. J. Anaesth, 1997, 79, 88-96.
108. Li, F.; Sugishita, K.; Su, Z.; Ueda, I.; Barry, W.H. Activation of connexin-43 hemichannels can elevate [Ca(2+)]i and [Na(+)]i in rabbit ventricular myocytes during metabolic inhibition. J. Mol. Cell Cardiol., 2001, 33, 2145-2155.
109. Shintani-Ishida, K.; Uemura, K.; Yoshida, K. Hemichannels in cardiomyocytes open transiently during ischemia and contribute to reperfusion injury following brief ischemia. Am. J. Physiol. Heart Circ. Physiol., 2007, 293, H1714-1720.
110. Saez, J.C.; Retamal, M.A.; Basilio, D.; Bukauskas, F.F.; Bennett, M.V. Connexin-based gap junction hemichannels: gating mechanisms. Biochim. Biophys. Acta., 2005, 1711, 215-224.
111. Schock, S.C.; Leblanc, D.; Hakim, A.M.; Thompson, C.S. ATP release by way of connexin 36 hemichannels mediates ischemic tolerance in vitro. Biochem. Biophys. Res. Commun., 2008, 368, 138-144.
112. Sarieddine, M.Z.; Scheckenbach, K.E.; Foglia, B.; Maass, K.; Garcia, I.; Kwak, B.R.; Chanson, M. Connexin43 modulates neutrophil recruitment to the lung. J. Cell Mol. Med., 2009, 13, 4560-4570.
113. Morel, S.; Braunersreuther, V.; Roth, I.; Chadjichristos, C.E.; de Wit, C.; Van Veen, T.A.; Kwak, B.R.; Mach, F. In American Heart Association. Circulation, 2008; Vol. 118 (18), pp. S-354.
114. Kwak, B.R.; van Veen, T.A.; Analbers, L.J.; Jongsma, H.J. TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels. Exp. Cell Res., 1995, 220, 456-463.
115. Kwak, B.R.; Jongsma, H.J. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol. Cell Biochem., 1996, 157, 93-99.
116. Jain, S.K.; Schuessler, R.B.; Saffitz, J.E. Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ. Res., 2003, 92, 1138-1144.
117. Piot, C.A.; Padmanaban, D.; Ursell, P. C.; Sievers, R.E.; Wolfe, C.L. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation, 1997, 96, 1598-1604.
118. Schulz, R.; Gres, P.; Skyschally, A.; Duschin, A.; Belosjorow, S.; Konietzka, I.; Heusch, G. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J., 2003, 17, 1355-1357.
119. Naitoh, K.; Yano, T.; Miura, T.; Itoh, T.; Miki, T.; Tanno, M.; Sato, T.; Hotta, H.; Terashima, Y.; Shimamoto, K. Roles of Cx43-associated protein kinases in suppression of gap junction-mediated chemical coupling by ischemic preconditioning. Am. J. Physiol. Heart. Circ. Physiol., 2009, 296, H396-403.
120. Schwanke, U.; Konietzka, I.; Duschin, A.; Li, X.; Schulz, R.; Heusch, G. No ischemic preconditioning in heterozygous connexin43-deficient mice, Am. J. Physiol. Heart Circ. Physiol., 2002, 283, H1740-1742.
121. Li, X.; Heinzel, F.R.; Boengler, K.; Schulz, R.; Heusch, G. Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. J. Mol. Cell Cardiol., 2004, 36, 161-163.
122. Miura, T.; Miki, T.; Yano, T. Role of the gap junction in ischemic preconditioning in the heart. Am. J. Physiol. Heart Circ. Physiol., 2010, 298, H1115-1125.
123. Li, G.; Whittaker, P.; Yao, M.; Kloner, R.A.; Przyklenk, K. The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc Pathol., 2002, 11, 158-165.
124. Miura, T.; Ohnuma, Y.; Kuno, A.; Tanno, M.; Ichikawa, Y.; Nakamura, Y.; Yano, T.; Miki, T.; Sakamoto, J.; Shimamoto, K. Protective role of gap junctions in preconditioning against myocardial infarction. Am. J. Physiol. Heart Circ. Physiol., 2004, 286, H214-221.
125. Papp, R.; Gonczi, M.; Kovacs, M.; Seprenyi, G.; Vegh, A. Gap junctional uncoupling plays a trigger role in the antiarrhythmic effect of ischaemic preconditioning. Cardiovasc Res., 2007, 74, 396-405.
126. Boengler, K.; Dodoni, G.; Rodriguez-Sinovas, A.; Cabestrero, A.; Ruiz-Meana, M.; Gres, P.; Konietzka, I.; Lopez-Iglesias, C.; Garcia-Dorado, D.; Di Lisa, F.; Heusch, G.; Schulz, R. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res., 2005, 67, 234-244.
127. Rodriguez-Sinovas, A.; Boengler, K.; Cabestrero, A.; Gres, P.; Morente, M.; Ruiz-Meana, M.; Konietzka, I.; Miro, E.; Totzeck, A.; Heusch, G.; Schulz, R.; Garcia-Dorado, D. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ. Res., 2006, 99, 93-101.
128. Heinzel, F.R.; Luo, Y.; Li, X.; Boengler, K.; Buechert, A.; Garcia-Dorado, D.; Di Lisa, F.; Schulz, R.; Heusch, G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ. Res., 2005, 97, 583-586.
129. Naitoh, K.; Ichikawa, Y.; Miura, T.; Nakamura, Y.; Miki, T.; Ikeda, Y.; Kobayashi, H.; Nishihara, M.; Ohori, K.; Shimamoto, K. MitoKATP channel activation suppresses gap junction permeability in the ischemic myocardium by an ERK-dependent mechanism. Cardiovasc Res., 2006, 70, 374-383.
130. Muller, A.; Gottwald, M.; Tudyka, T.; Linke, W.; Klaus, W.; Dhein, S. Increase in gap junction conductance by an antiarrhythmic peptide. Eur. J. Pharmacol., 1997, 327, 65-72.
131. Muller, A.; Schaefer, T.; Linke, W.; Tudyka, T.; Gottwald, M.; Klaus, W.; Dhein, S. Actions of the antiarrhythmic peptide AAP10 on intercellular coupling. Naunyn Schmiedebergs Arch. Pharmacol., 1997, 356, 76-82.
132. Aonuma, S.; Kohama, Y.; Akai, K.; Komiyama, Y.; Nakajima, S.; Wakabayashi, M.; Makino, T. Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem. Pharm. Bull (Tokyo), 1980, 28, 3332-3339.
133. Grover, R.; Dhein, S. Structure-activity relationships of novel peptides related to the antiarrhythmic peptide AAP10 which reduce the dispersion of epicardial action potential duration. Peptides, 2001, 22, 1011-1021.
134. Kjolbye, A.L.; Knudsen, C.B.; Jepsen, T.; Larsen, B.D.; Petersen, J.S. Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies. J. Pharmacol. Exp. Ther., 2003, 306, 1191-1199.
135. Weng, S.; Lauven, M.; Schaefer, T.; Polontchouk, L.; Grover, R.; Dhein, S. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J. 2002, 16, 1114-1116.
136. Dhein, S.; Weng, S.; Grover, R.; Tudyka, T.; Gottwald, M.; Schaefer, T.; Polontchouk, L. Protein kinase Calpha mediates the effect of antiarrhythmic peptide on gap junction conductance. Cell Commun Adhes., 2001, 8, 257-264.
137. Axelsen, L.N.; Stahlhut, M.; Mohammed, S.; Larsen, B.D.; Nielsen, M.S.; Holstein-Rathlou, N.H.; Andersen, S.; Jensen, O.N.; Hennan, J.K.; Kjolbye, A.L. Identification of ischemia-regulated phosphorylation sites in connexin43: A possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123). J. Mol. Cell Cardiol., 2006, 40, 790-798.
138. Jozwiak, J.; Dhein, S. Local effects and mechanisms of antiarrhythmic peptide AAP10 in acute regional myocardial ischemia: electrophysiological and molecular findings. Naunyn Schmiedebergs Arch. Pharmacol., 2008, 378, 459-470.
139. Easton, J.A.; Petersen, J. S.; Martin, P.E. The anti-arrhythmic peptide AAP10 remodels Cx43 and Cx40 expression and function. Naunyn Schmiedebergs Arch. Pharmacol., 2009, 380, 11-24.
140. Stahlhut, M.; Petersen, J.S.; Hennan, J.K.; Ramirez, M.T. The antiarrhythmic peptide rotigaptide (ZP123) increases connexin 43 protein expression in neonatal rat ventricular cardiomyocytes. Cell Commun Adhes., 2006, 13, 21-27.
141. Hagen, A.; Dietze, A.; Dhein, S. Human cardiac gap-junction coupling: effects of antiarrhythmic peptide AAP10. Cardiovasc. Res., 2009, 83, 405-415.
142. Clarke, T.C.; Thomas, D.; Petersen, J.S.; Evans, W.H.; Martin, P.E. The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43. Br J. Pharmacol., 2006, 147, 486-495.
143. Shibayama, J.; Lewandowski, R.; Kieken, F.; Coombs, W.; Shah, S.; Sorgen, P.L.; Taffet, S.M.; Delmar, M. Identification of a novel peptide that interferes with the chemical regulation of connexin43. Circ. Res., 2006, 98, 1365-1372.
144. Lewandowski, R.; Procida, K.; Vaidyanathan, R.; Coombs, W.; Jalife, J.; Nielsen, M.S.; Taffet, S.M.; Delmar, M. RXP-E: a connexin43-binding peptide that prevents action potential propagation block. Circ. Res., 2008, 103, 519-526.
145. Verma, V.; Larsen, B.D.; Coombs, W.; Lin, X.; Spagnol, G.; Sorgen, P.L.; Taffet, S.M.; Delmar, M. Novel pharmacophores of connexin43 based on the "RXP" series of Cx43-binding peptides. Circ. Res., 2009, 105, 176-184.